Regulatory News:
Amplitude Surgical (Paris:AMPLI):
Pursuant to the liquidity contract entrusted to Natixis, on 31 December 2015, the following assets appeared on the liquidity account:
- Number of shares: 35,511
- Cash balance of the liquidity account: €320,776
As a reminder, when the contract was implemented on July 27, 2015 the following resources were booked to the liquidity contract:
- €500,000
Next financial press release: H1 2015/16 sales, Wednesday February 3, 2016
About Amplitude Surgical
Founded in 1997 in Valence, France,
Amplitude Surgical is a leading French player on the global surgical
technology market for lower-limb orthopedics. Amplitude Surgical
develops and markets high-end products for orthopedic surgery covering
the main disorders affecting the hip, knee and extremities, and notably
foot and ankle surgery. Amplitude Surgical develops, in close
collaboration with surgeons, numerous high value-added innovations in
order to best meet the needs of patients, surgeons and healthcare
facilities. A leading player in France, Amplitude Surgical is developing
abroad through its subsidiaries and a network of exclusive distributors
and agents. Amplitude Surgical operates on the lower-limb market through
the intermediary of its Novastep subsidiaries in France and the United
States. Amplitude Surgical distributes its products in more than 30
countries. On June 30, 2015, Amplitude Surgical had a workforce of 248
staff and recorded sales of 71.1 million euros and an EBITDA margin of
close to 19%.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160115005180/en/